Skip to content
Business Times – Lifestyle
Author:
Regenerative Medical Technology Group
RMTG’s ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
September 17, 2026
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
September 14, 2026
RMTG Cellgenic Begins Commercial Activity in Colombia
September 8, 2026
Cellgenic Establishes Local Commercial Presence in Brazil
September 3, 2026
RMTG’s Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
September 1, 2026
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
August 28, 2026
RMTG Expands Cellgenic’s Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
August 18, 2026
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
August 5, 2026
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
July 23, 2026
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
June 23, 2026
1
2
Next Page
→